Toople Investors - TOOP

Toople Investors - TOOP

Stock Name Stock Symbol Market Stock Type
Toople Plc TOOP London Ordinary Share
  Price Change Price Change % Stock Price Last Trade
0.00 0.0% 0.0085 00:00:00
Open Price Low Price High Price Close Price Previous Close
more quote information »
Industry Sector

Top Investor Posts

Top Posts
Posted at 23/11/2022 21:23 by aim_high1

Fingers crossed there will be some kind of return for investors

Posted at 27/7/2022 07:37 by tell sid
Presumably it will be cheaper to list on AQSE so reducing costs for the Company, and for investors the shares will still qualify for holding in an ISA and SIPP.
Posted at 26/7/2022 17:25 by dodge_city
They are not going bust they are just going to rip off their investors. This is turning out to be a scam, some of their mates with a couple of mill spare will get the company for next to nothing.
Posted at 28/2/2022 13:34 by investrip
But Lee, Those TR1s are connected parties, theyre not true investors.

Mike Staten proven time and time again to work with Novum and Charlie
Oberlon.... Brokered by Novum...

Theres no big investors here, its all manipulation

Check the comments here
Mike Staten. A large investor who is not intent on losing money. He will not. But small shareholders in Ascent Resources are going to. And potential investors. Parsons. Dennan. Staten. Novum Securities and Jon Belliss. Expect Charles Brook-Partridge and Sebatian Marr to turn up as well. The former is a director of Novum. Novum Securities are the brokers for Nuog. Nuog is now suspended whilst two directors look for a RTO for the company. It could get delisted altogether. C4 Energy, where Parsons is one of the directors, bought the debt there and parachuted in two of their shareholders, one of which is Dennan. When Nuog shares were still listed Staten, Brook-Partidge and Marr each bought 3% of the company at the same time, announced by RNS. When the shares rose in a pump and dump they all sold 3 days later. They made a tidy profit but mug punters were left with devalued shares which were subsequently suspend and could be worth nothing. Ascent is their new toy. Explains the arrival of Spreadex and mAlign Research. Expect a rinse and repeat. Recent buyers of AST shares should sell. Potential new buyers should run for the hills. Leave this to the mugs. At Nuog there was a large shareholder, Gary Smith, who tweeted his share buying and was at about 10% just before suspension. Mugs followed him and bought and now rue the fact. Be very careful. These people are all interconnected. You are not On the inside. You are a mug punter. A victim. Let this disgrace unfold from afar. Expect the good doctor to arrive. These people are all conspiring against small shareholders and include the AST BOD. Disgraceful.

Posted at 11/1/2022 11:11 by wapper
Just giving fellow investors a potential decent gain but please DYOR . I always appreciate such pointers but we are all different I guess. No offence intended
Posted at 10/1/2022 15:31 by queenwood
I just don’t understand some investors the first opportunity they sell for a few percent still it’s up to them I suppose
Posted at 10/1/2022 09:05 by leewink1
Whatever way you look at it, several TR1 and contract wins in the recent weeks says enough, you don't load up that amount for nothing, either the results very soon will be a clue as to why, or the coming year will be the point I'm sure most investors (not guessers) will be waiting to hear over, makes your choices, but again you don't throw very good amounts of money at bad things or choices.
Posted at 10/1/2022 08:39 by wapper
My take on TOOP is that there are 3 scenarios . Doomster version where it spirals down to oblivion. It ticks along with zero growth raising capital along the way. Or we see growth ranging between acceptable and exponential. I'm in the latter camp. It's valued at only £2.6 million. Every Aim investor knows that share prices can change by large percentages daily based on rumours, P & D etc and on genuine news / progress or lack of it. So it's easy: make your mind up which camp you are in and act accordingly. If in same camp as I am then stay invested or become an investor or add whenever you feel it's right for you. Otherwise sell or don't invest.
Posted at 23/12/2021 14:13 by leewink1
If you've sold move on, I'm awaiting final results in a few weeks to see their way forward, no one's ramping, but seemingly plain buying on news of the handful of TR1 over the last days, that's choices made by individuals, like you say, you make your choices alone, there's no warnings here from me, just major investors investing and that's enough for me, there's only one reason to doubt a share when you're not in it, and that doesn't take to much working out, again, move on.
Posted at 09/7/2021 23:18 by investrip
Nope, 100% correct. Take a look at the placing RNS

October 20
Novum Securities Limited will be issued 35,200,511 warrants exercisable at the Placing Price.

This was 0.11....

Jan 20

The Placing is conditional on the Resolutions being passed at the General Meeting and on Admission occurring on or before 18 February 2020 or such later date as may be agreed by Novum, Turner Pope, Cairn and the Company. Total expenses in relation to the Placing and Admission are £280,000.

Gross Placing of £1.2 Million... so £280k of that went straight on commission.
Oh and
The Company has also agreed, conditional on Admission, to issue warrants (i) to Turner Pope and to Novum to subscribe for 74,130,000 new Ordinary Shares and (iii) to Cairn to subscribe for 5,000,000 new Ordinary Shares (the "2020 Warrants"). Each 2020 Warrant entitles the holder to subscribe for 1 new Ordinary Share at the Placing Price at any time during the period commencing on Admission and expiring at midnight on the second anniversary thereof.

Sept 18 £2.2 million placing

Conditional on Admission to issue the Broker Warrants to Novum and
Turner Pope to subscribe for 33,000,000 new Ordinary Shares in aggregate, exercisable at
0.5 pence.
The Company has appointed Novum to act as placing agent in respect of the
Placing. Novum agrees to act as placing agent and to use reasonable endeavours to
place new Ordinary Shares with investors pursuant to the Placing. The fees charged
by Novum are as follows:
a. sales commission calculated at a rate of 7.5% (seven and a half per cent.) of
the gross aggregate value of the funds raised from investors introduced by
Novum in the Placing (deductible from the proceeds of the Placing); and
b. 50% of the total sales commission calculated at a rate of 7.5% (seven and a
half per cent.) of the gross aggregate value of the funds raised from Market
Counterparties in the Placing (deductible from the proceeds of the Placing).

Placing 2017
A sales commission of 5% of the gross proceeds raised by Novum;
The issue of such number of New Warrants over new Ordinary Shares in the Company
exerciseable at the Initial Issue Price as equals 5.0% (five per cent.) of the gross
aggregate value of the funds raised from investors introduced by Novum pursuant to
the Subscription and Offer

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221202 07:49:02